Beijing Beilu Pharmaceutical Co., Ltd.

Recently, Beilu Pharma received the "Drug Registration Certificate" for its Vonoprazan Fumarate Tablets, approved and issued by the National Medical Products Administration (NMPA).

Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the "Marketing Authorization" (MA) issued by the Netherlands Medicines Evaluation Board (MEB) in accordance with the relevant regulations of the European Medicines Agency.